SCHEMBL3344481

SCHEMBL3344481

O=C1NCC2=C1C(c1cccc(O)c1)NC(=S)N2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 1/20 0.52
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
KDM4E B2RXH2 3/20 0.50
MAPT P10636 2/20 0.50
GUSB P08236 1/20 0.46
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
ALDH1A1 P00352 5/20 0.43
GAA P10253 2/20 0.40
KIF11 P52732 4/20 0.38
TRPA1 O75762 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
ABCC9 O60706 1/20 0.36
ABCC8 Q09428 1/20 0.36
KCNJ11 Q14654 1/20 0.36
KCNJ8 Q15842 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3343387 0.88 DHFR (0.50) DHFRMEN1KMT2AKDM4EMAPT
SCHEMBL3338050 0.80 DHFR (0.52) DHFRMEN1KMT2AKDM4EMAPT
(S)-Enastron SCHEMBL5177968 0.79 ALDH1A1 (0.72) DHFRMEN1KMT2AKDM4EMAPT
SCHEMBL9701173 0.78 DHFR (0.62) DHFRKDM4EMAPTGUSBALDH1A1
SCHEMBL3338330 0.78 DHFR (0.50) DHFRMEN1KMT2AKDM4EMAPT
Dimethylenastron SCHEMBL5178439 0.77 ALDH1A1 (0.65) DHFRMEN1KMT2AKDM4EGUSB
SCHEMBL13302762 0.77 DHFR (0.52) DHFRMEN1KMT2AKDM4EGUSB
SCHEMBL12595219 0.73 TRPA1 (0.61) DHFRMEN1KMT2AKDM4EMAPT
SCHEMBL29044382 0.69 MAPT (0.73) MEN1KMT2AKDM4EMAPTCYP1A2
SCHEMBL29357488 0.69 DHFR (0.54) DHFRMEN1KMT2AKDM4EGUSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152206-A1 Bicyclic Dihydropyrimidines and Uses Thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2010-06-17 US disclosed
US-20100152206-A1 Bicyclic Dihydropyrimidines and Uses Thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2010-06-17 US disclosed
US-20100152206-A1 Bicyclic Dihydropyrimidines and Uses Thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2010-06-17 US disclosed
WO-2006074293-A2 BICYCLIC DIHYDROPYRIMIDINES AS EG5 INHIBITORS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2006-07-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152206-A1 Bicyclic Dihydropyrimidines and Uses Thereof KIF5A, KIF5C, KIF5B DHFR 45/4885MEN1 2916/4885KMT2A 1008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.